Analysen von Keyur Parekh
| 03.05.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.05.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 28.04.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 27.04.17 | GSK buy | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.03.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 16.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.03.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 03.03.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.03.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 28.02.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 28.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 28.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 28.02.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 23.02.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 17.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 15.02.17 | GSK buy | Goldman Sachs Group Inc. | |
| 09.02.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 09.02.17 | GSK buy | Goldman Sachs Group Inc. | |
| 09.02.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.02.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 24.01.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.01.17 | GSK buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.01.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 24.01.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 23.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 12.01.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.01.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.01.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 21.12.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.12.16 | GSK buy | Goldman Sachs Group Inc. | |
| 01.12.16 | GSK buy | Goldman Sachs Group Inc. | |
| 30.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 11.11.16 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.11.16 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 07.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 04.11.16 | Roche buy | Goldman Sachs Group Inc. | |
| 31.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |